Vichem Chemie Research

Vichem Chemie Research is a Budapest-based, private contract research organization (CRO) and drug discovery company with a 30+ year history. Its core business model combines fee-for-service chemistry and biology work with the development of its own proprietary chemical libraries and internal therapeutic programs, primarily focused on kinase inhibitors. The company leverages strategic alliances and has received grant funding from Hungarian and European sources, indicating a hybrid revenue model of services and grants while advancing its pipeline.

Integrated small molecule drug discovery platform specializing in kinase inhibitors, featuring proprietary compound libraries (Nested Chemical Library™, Allosteric Library), full-service chemistry/biology capabilities from hit-finding to lead optimization, and custom synthesis.

Competes with global CROs (e.g., Evotec, WuXi AppTec) and niche chemistry service providers. In kinase inhibitor discovery, faces competition from numerous biopharma companies and biotechs with clinical-stage assets. Differentiation lies in deep kinase expertise, proprietary libraries, and integrated service-pipeline hybrid model.